408 related articles for article (PubMed ID: 20688564)
21. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Mar; 49(5):589-598. PubMed ID: 30681172
[TBL] [Abstract][Full Text] [Related]
22. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma.
Huang CE; Yang YH; Chen YY; Chang JJ; Chen KJ; Lu CH; Lee KD; Chen PC; Chen CC
J Viral Hepat; 2017 Oct; 24(10):885-894. PubMed ID: 28375587
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study).
Abe SK; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Sasazuki S; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol; 2015 Aug; 39(4):562-6. PubMed ID: 26149122
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV.
Besson C; Noel N; Lancar R; Prevot S; Algarte-Genin M; Rosenthal E; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Cheret A; Arvieux C; Katlama C; Salmon D; Boué F; Costello R; Hendel-Chavez H; Taoufik Y; Fontaine H; Coppo P; Mounier N; Delobel P; Costagliola D;
AIDS; 2020 Mar; 34(4):599-608. PubMed ID: 31833850
[TBL] [Abstract][Full Text] [Related]
25. Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy.
Kim YM; Jeong SH; Kim JW; Lee SH; Hwang JH; Park YS; Kim N; Lee JS; Kim HY; Lee DH
J Clin Virol; 2011 Aug; 51(4):241-5. PubMed ID: 21628103
[TBL] [Abstract][Full Text] [Related]
26. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
[TBL] [Abstract][Full Text] [Related]
27. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
28. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
[TBL] [Abstract][Full Text] [Related]
29. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Kommoss FKF; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy.
Taborelli M; Polesel J; Montella M; Libra M; Tedeschi R; Battiston M; Spina M; Di Raimondo F; Pinto A; Crispo A; Grimaldi M; Franceschi S; Dal Maso L; Serraino D
Infect Agent Cancer; 2016; 11():27. PubMed ID: 27340429
[TBL] [Abstract][Full Text] [Related]
31. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
32. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadry DY; Elbahnasawy MA; Mansour MT; El Gebaly OK; Aziz H; Kamel MM; Abdel-Moneim AS; Radwan S
Int J Immunopathol Pharmacol; 2023; 37():3946320231207342. PubMed ID: 37859403
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
34. Chronic hepatitis B virus infection and risk of dyslipidaemia: A cohort study.
Joo EJ; Chang Y; Yeom JS; Cho YK; Ryu S
J Viral Hepat; 2019 Jan; 26(1):162-169. PubMed ID: 30267602
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus infection and development of chronic kidney disease: a cohort study.
Hong YS; Ryu S; Chang Y; Caínzos-Achirica M; Kwon MJ; Zhao D; Shafi T; Lazo M; Pastor-Barriuso R; Shin H; Cho J; Guallar E
BMC Nephrol; 2018 Dec; 19(1):353. PubMed ID: 30537940
[TBL] [Abstract][Full Text] [Related]
36. Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study.
Crump C; Sundquist K; Sieh W; Winkleby MA; Sundquist J
J Natl Cancer Inst; 2012 Jun; 104(12):923-30. PubMed ID: 22623506
[TBL] [Abstract][Full Text] [Related]
37. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies.
Li M; Gan Y; Fan C; Yuan H; Zhang X; Shen Y; Wang Q; Meng Z; Xu D; Tu H
J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Yamauchi N; Maruyama D; Choi I; Atsuta Y; Sakai R; Miyashita K; Moriuchi Y; Tsujimura H; Kubota N; Yamamoto G; Igarashi T; Izutsu K; Yoshida S; Kojima K; Uchida T; Inoue Y; Tsukamoto N; Ohtsuka E; Suzuki S; Inaguma Y; Ichikawa S; Gomyo H; Ushijima Y; Nosaka K; Kurata M; Tanaka Y; Ueda R; Mizokami M; Kusumoto S
Cancer Sci; 2021 May; 112(5):1943-1954. PubMed ID: 33576088
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
Joo EJ; Chang Y; Yeom JS; Ryu S
Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
